Skip to main content


Firm News

Mayer Brown advised Fosun Pharmaceutical on their acquisition of an interest in miacom

2 July 2014
Düsseldorf – Leading global law firm Mayer Brown advised Shanghai Fosun Pharmaceutical Group (Fosun Pharma) on their acquisition of an interest (37 percent) in miacom Diagnostics GmbH in Düsseldorf as well as on the conclusion of a cooperation agreement.
Fosun Pharma, based in Shanghai, is a leading healthcare company in China. Established in 1994, it has been listed on Shanghai Stock Exchange since August 1998. Fosun Pharma develops, produces and distributes pharmacueticals, healthcare services, diagnostic products and medical devices.

Miacom diagnostics, established in 2006, specializes on medical tests for the detection of pathogens causing infections such as sepsis and pneumonia.

The Mayer Brown working on the transaction encompassed partners Carsten Flaßhoff (lead, Corporate, Düsseldorf), Dr. Marco Wilhelm (lead, Corporate, Frankfurt), Betty F.K. Tam (Corporate, Shanghai), Dr. Marius Boewe (Public Law, Düsseldorf) as well as associates Gavin W.H. Guo (Corporate, Shanghai), Konstantin von Werder (IP, Frankfurt) and Roman Wille (Corporate, Düsseldorf).

Media Contact

  • PR Germany
    T +49 69 7941 0

Related Information

The Build a Report feature requires the use of cookies to function properly. Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently. If you do not accept cookies, this function will not work. For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.